Aphasia
Conditions
Brief summary
Transcranial Magnetic Stimulation (TMS) has been demonstrated to improve language function in subjects with chronic aphasia in a number of small studies, many of which did not include a control group. Although the treatment appears promising, data to date do not permit an adequate assessment of the utility of the technique. The investigators propose to study the effects of TMS combined with Constraint Induced Language Therapy (CILT) in 75 subjects with chronic aphasia. Subjects will be randomized in a 2:1 ratio to TMS with CILT or sham TMS with CILT. One Hz TMS at 90% motor threshold will be delivered to the right inferior frontal gyrus for 20 minutes in 10 sessions over 2 weeks; language therapy will be provided for one hour immediately after the conclusion of each session of TMS. Change from baseline in the Western Aphasia Battery Aphasia Quotient at 6 months after the end of TMS treatment will serve as the primary outcome measure.
Detailed description
TMS is a technique by which a brief electrical current is induced in brain tissue causing a brief suppression of the excitability of the underlying tissue; the technique, which was introduced in the 1980s and has been extensively used around the world, has been shown to transiently improve or disrupt specific cognitive operations. To achieve this end, a coil is positioned against the subject's head. The delivery of a single pulse begins with the discharge of current from a capacitor into a circular or figure-of-eight coil; this electrical current generates a brief magnetic field of up to 2.2 Tesla. As the pulse of electricity has a rise time of 0.2 ms. and a duration of 1 ms., the magnetic field changes in intensity quite rapidly. Because the magnetic field passes freely through the scalp, skull, and meninges, the flux in the magnetic field induces a small electric field in the brain that transiently alters neural activity. TMS may be delivered in a variety of ways. The investigators propose to use 1 Hz TMS; that is, TMS pulses will be delivered at a frequency of 1/second. This style of TMS is assumed to be inhibitory in that it transiently suppresses the function of the cortex under the coil. Using the figure-of-eight coil to be employed here, TMS is thought to reduce activity in approximately 1 cubic cm. of cortex. Many investigators have employed TMS with a frequency of 1 Hz for periods of 20 minutes and longer; mild behavioral deficits are often present for several minutes in these studies. The baseline phase will consist of 3 sessions, each lasting 1-2 hours depending on the stamina of the subject. The point of the baseline testing is to characterize the subject's language function. To that end, a number of standard language and neuropsychological tasks will be administered. These include the Western Aphasia Battery, Pyramids and Palm Trees test, Figural Fluency Test, word and non-word repetition tasks, the Nicholas and Brookshire Narratives, CILT stimulus naming, and Northwestern Assessment of Verbs and Sentences. Additionally, during the baseline, subjects will undergo MRI of the brain or, if they have a contraindication to MRI, a CAT scan of the head. No contrast will be used. In the treatment phase, there will be 10 TMS sessions over 2 consecutive weeks in which 20 minutes (1200 pulses) of 1 Hz TMS at 90% motor threshold will be delivered to the inferior pars triangularis. Each TMS treatment session will be immediately followed by a 60-90 minute session of CILT There will be two 3-month post-treatment visits and two 6-month post-treatment visits in which the full battery of language and cognitive assessments will be repeated. Subjects who are able to undergo MRI scanning will have anatomic and fMRI scans at the first 6-month post-treatment visit. The investigators will pair TMS with CILT which has been shown to have positive outcomes in post-stroke aphasia. CILT invokes use-dependent learning in communicative interactions by requiring spoken output and restricting use of alternative forms of communication, such as gestures. The investigators will use a dual card-matching task modeled after Maher et al. As in the original CILT design, the participant interacts verbally with a conversational partner (here, the speech language pathologist), in turn requesting a card of given description and complying with the partner's request. In this way, the treatment targets both production and comprehension. Moreover, as verbal targets increase in linguistic complexity across the protocol (a ball, throw a ball; Do you have a ball?), a variety of lexical and phrasal structures are targeted. Studies of CILT have reported gains on multiple language behaviors, supporting its broad engagement of the language network.
Interventions
Active TMS will be at 90% motor threshold
Sham TMS will be administered
60-90 minutes of CILT will be administered during each treatment session
Sponsors
Study design
Masking description
The individual administering TMS will keep the master file of subject assignments, but all other individuals in contact with the subject or their data will be unaware of group assignment. Participants will not be informed of their assignment to active or sham status.
Intervention model description
Participants will be randomized to either TMS or sham TMS in a 2:1 allocation ratio.
Eligibility
Inclusion criteria
* Clinical evidence and MRI or CT verification of a single left hemisphere stroke with moderate to severe aphasia. * Suffered their stroke at least 6 months prior to their testing * Must be able to understand the nature of the study, and give informed consent
Exclusion criteria
* Multiple strokes (excluding small lacunar strokes) as defined by brain imaging * History of substance abuse * Previous head trauma with loss of consciousness for more than 5 minutes * Psychiatric illness (We note that subjects will be assessed with the 15-item Geriatric Depression scale. Because depression is very difficult to evaluate in aphasic subjects, potential subjects will not be excluded on the basis of the depression score) * Chronic exposure to medications that might be expected to have lasting consequences for the central nervous system (e.g. haloperidol, dopaminergics) * History of or neuropsychological findings suggestive of dementia
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in WAB-AQ | 6-months post-treatment | The primary outcome measure will be the change in score on the Western Aphasia Battery Aphasia Quotient (WAB-AQ), a score assessing overall aphasia recovery. Scores can range from 0-100, with higher scores representing better outcomes. 0-25 is very severe, 26-50 is severe, 51-75 is moderate, and 76-above is mild. A score of 93 or higher is considered recovered. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Percentage of Items Correct on the PNT | 6-months post-treatment | The secondary outcome measure will be change in naming accuracy on the Philadelphia Naming Test (PNT). PNT naming accuracy is measured as a percentage from 0% to 100% with higher percentages meaning better naming ability. The task involves naming 175 pictures of common objects. |
Countries
United States
Participant flow
Recruitment details
Participants were recruited from 2019-2024 from the Hospital of the University of Pennsylvania, surrounding Philadelphia area medical centers and aphasia support groups.
Pre-assignment details
A total of 36 participants did not qualify due to medical contraindications (14) or aphasia severity (22). Nine participants dropped out of the study prior to randomization due to safety concerns (1), inability to complete MRI scan (3), lost to follow-up (2), travel concerns (1), no longer interested in participating (2).
Participants by arm
| Arm | Count |
|---|---|
| Active TMS Participants will receive 10 TMS sessions over 2 consecutive weeks in which 20 minutes (1200 pulses) of 1 Hz active TMS will be delivered to the inferior pars triangular.
Each TMS treatment session will be immediately followed by a 60-90 minute session of Constrained Induced Language Therapy (CILT).
Active TMS: Active TMS will be at 90% motor threshold
CILT: 60-90 minutes of CILT will be administered during each treatment session | 26 |
| Sham TMS Participants will take part in 10 Sham TMS sessions over 2 consecutive weeks for 20 minutes each day. Sham TMS mimics the sensory experience (look, sound and feel) of active TMS but does not stimulate the brain. Sham TMS will be administered with a sham TMS coil that looks and sounds like the active coil but does not generate a magnetic field. The sham TMS will target the same brain location - left inferior pars triangularis.
Each sham TMS treatment session will be immediately followed by a 60-90 minute session of Constrained Induced Language Therapy (CILT). | 15 |
| Total | 41 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Withdrawal by Subject | 1 | 0 |
Baseline characteristics
| Characteristic | Active TMS | Sham TMS | Total |
|---|---|---|---|
| Age, Continuous | 57.73 years STANDARD_DEVIATION 10.62 | 61.67 years STANDARD_DEVIATION 10.87 | 59.17 years STANDARD_DEVIATION 10.88 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 22 Participants | 0 Participants | 22 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 3 Participants | 13 Participants | 16 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 1 Participants | 2 Participants | 3 Participants |
| Philadelphia Naming Test, Items Correct | 110.4 number of items correct STANDARD_DEVIATION 57 | 114.0 number of items correct STANDARD_DEVIATION 42.6 | 111.7 number of items correct STANDARD_DEVIATION 51.8 |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 2 Participants | 0 Participants | 2 Participants |
| Race (NIH/OMB) Black or African American | 5 Participants | 4 Participants | 9 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 1 Participants | 1 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 1 Participants | 1 Participants | 2 Participants |
| Race (NIH/OMB) White | 18 Participants | 9 Participants | 27 Participants |
| Sex: Female, Male Female | 13 Participants | 4 Participants | 17 Participants |
| Sex: Female, Male Male | 13 Participants | 11 Participants | 24 Participants |
| Western Aphasia Battery (WAB-AQ) Score | 66.6 score on a scale STANDARD_DEVIATION 19.9 | 68.8 score on a scale STANDARD_DEVIATION 18.5 | 67.4 score on a scale STANDARD_DEVIATION 18.7 |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 26 | 0 / 15 |
| other Total, other adverse events | 13 / 26 | 7 / 15 |
| serious Total, serious adverse events | 1 / 26 | 1 / 15 |
Outcome results
Change in WAB-AQ
The primary outcome measure will be the change in score on the Western Aphasia Battery Aphasia Quotient (WAB-AQ), a score assessing overall aphasia recovery. Scores can range from 0-100, with higher scores representing better outcomes. 0-25 is very severe, 26-50 is severe, 51-75 is moderate, and 76-above is mild. A score of 93 or higher is considered recovered.
Time frame: 6-months post-treatment
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Active TMS | Change in WAB-AQ | 3.0 score on a scale | Standard Deviation 3.8 |
| Sham TMS | Change in WAB-AQ | 2.8 score on a scale | Standard Deviation 5.9 |
Change in Percentage of Items Correct on the PNT
The secondary outcome measure will be change in naming accuracy on the Philadelphia Naming Test (PNT). PNT naming accuracy is measured as a percentage from 0% to 100% with higher percentages meaning better naming ability. The task involves naming 175 pictures of common objects.
Time frame: 6-months post-treatment
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Active TMS | Change in Percentage of Items Correct on the PNT | 3.4 score on a scale | Standard Deviation 8.9 |
| Sham TMS | Change in Percentage of Items Correct on the PNT | 3.4 score on a scale | Standard Deviation 9.1 |